Please refer to each product’s datasheet for specific recommendations. Generally, for short-term (1-2 weeks) storage of antibodies, refrigerate at 4ºC. For longer storage times, aliquot and maintain at -20ºC or below in a non-frost-free freezer. Avoid multiple freeze-thaw cycles. If not stored properly, the performance of the product may be compromised.
The volume of the aliquots can be adjusted according to the particular requirements of the experiment(s) to be performed. However, since small volumes are more susceptible to external temperature, we recommend aliquots greater than 10 ul.
GeneTex does make some experimental protocols available on our website, though it is frequently the case that each lab will have their own procedures that will require optimization for each antibody/reagent. Please click here to view a list of general protocols.
Samples should be lysed in ice-cold buffer containing appropriate protease inhibitors (and phosphatase inhibitors for phosphorylated targets). Always keep the samples on ice and freeze aliquots to avoid multiple freeze-thaw cycles.
GeneTex is unable to guarantee that a diluted antibody will perform consistently when reused. This must be tested empirically by the researcher.
This usually results from structural alteration or variants of the protein, including post-translational modification, cleavage, isoforms or polymerization. Depending on the biology of the protein of interest, there may be specific bands that are smaller or larger than expected.
Typically, SDS-PAGE allows electrophoretic separation of proteins in a sample by molecular weight (MW), with larger proteins migrating more slowly than smaller proteins. Loading protein markers of established size (e.g., Trident Prestained Protein Ladders) allows researchers to approximate the MW of their target protein. In the simplest scenario, the MW of a protein is determined by its amino acid constituents. However, there are various factors that can affect protein migration on SDS-PAGE, resulting in an observed signal that differs from the expected MW.
These factors include:
GeneTex is unable to guarantee that an antibody will work for an unstated species or application. In order to confirm that an antibody will meet your needs, please contact technical@stratech.co.uk for more information prior to purchasing.
Possible reasons:
a. Inadequate cell lysis Ensure that cell lysis and protein extraction are properly.
b. Protein degradation Always add protease inhibitors to lysis buffer prior to cell lysis and perform protein extraction on ice to avoid protein degradation.
c. Low expression of protein of interest Increasing the amount of protein extract loaded on your gel may resolve this problem. If the protein of interest is expressed in a tissue- or cell type- specific manner, be sure to choose this specific tissue or cell type for your experiments.
d. The protein of interest is enriched in a specific organelle Biochemical fractionation of subcellular compartments may be necessary to detect this type of protein.
e. Expression of the protein of interest is induced only under certain conditions Check the relevant literature to see if any treatment (e.g., starvation or chemical agents) is required to induce adequate protein expression.
a. Incomplete transfer Make sure the PVDF membrane remains wet during the transfer. PVDF membranes must be “activated” by exposure to methanol prior to transfer. Consult the instruction manual explaining usage of PVDF membrane before the experiment. Reversible Ponceau S membrane staining is an easy step to confirm protein transfer.
b. Over-transfer Please adjust the electrical current and time frame for transfer. The conditions should be optimized according to the molecular weight of the target protein. Note that high molecular weight proteins may require a longer time to transfer.
a. Insufficient primary or secondary antibody being used Use the recommended antibody dilutions described on the product datasheet as a starting point for your experiment. For weakly expressed proteins, it may be necessary to increase the concentration of antibody. Avoid reusing primary antibodies whenever possible.
b. Insufficient incubation time with the primary antibody A one-hour incubation at room temperature is usually sufficient for detection of most proteins. In some cases, it may be necessary to increase the incubation time (e.g., incubate overnight at 4°C).
c. Incorrect secondary antibody used Confirm that the appropriate secondary antibody is used. Select a secondary antibody directed against the specific host species and immunoglobulin type for the primary antibody (i.e., a primary antibody raised in rabbit with isotype IgG will require an anti-rabbit IgG secondary antibody). All host species and isotype information can be found on the datasheet of the primary antibody.
d. Excessive washing of the membrane Three washes of 5~10 minutes each are sufficient to wash out the non-specific binding in most cases. Avoid excessive washing of the membrane, as this may reduce the amount of primary antibody bound to the target antigen.
Make sure the ECL reagents have not expired. ECL reagent will lose activity over time, so always prepare the reagent immediately prior to the detection reaction.
Sodium azide (NaN3) is an inhibitor of HRP and may quench HRP activity. Ensure that there is no sodium azide in the antibody dilution buffer and thoroughly wash the membrane before the detection reaction.
Possible reasons:
Post-translational modification(s) may result in multiple bands. The modified protein usually appears as a band(s) above the predicted molecular weight. Check the literature to see if there are any known modifications of the target protein.
Protein degradation also results in multiple bands. The degraded protein is commonly seen as multiple bands below the predicted molecular weight. Ensure that protease inhibitors have been added to the protein extraction buffer. Avoid repeated freeze/thaw cycles of the cell lysate.
Properly boil the samples to ensure appropriate protein denaturation. Remember that freshly added dithiothreitol (DTT) or 2-mercaptoethanol (2-ME) in the sample buffer is required for the reduction of disulfide bonds.
Refer to literature and search on BLAST for the protein of interest. Load a recommended positive control.
Decrease the concentration of primary antibody or reduce the incubation time.
Decrease the concentration of secondary antibody. Incubate with a secondary antibody only (without primary antibody) as a control.
Increase the duration of washing or increase the concentration of detergents in the wash buffer.
Possible reasons:
Adjust the concentration of the primary or secondary antibody.
Decrease the time of exposure of the membrane.
Increase the incubation time with blocking buffer, and ensure that an appropriate blocking buffer is being used.
Increase the duration of washing or increase the concentration of detergents in the wash buffer.
Change the blocking buffer (e.g., from non-fat milk to 3%~5% BSA or use a protein-free blocking buffer)
Keep the PVDF membrane wet during incubation.
Select the appropriate type of membrane for your experiment (e.g., PVDF membrane is more sensitive than nitrocellulose membrane).
Possible reasons:
Decrease the amount of protein loaded on the gel.
Verify that the SDS-PAGE gel mix is correctly prepared and that the poured gel polymerizes completely. For gels stored at 4°C, confirm that they have not dried out.
Possible reasons:
Reduce the concentration of primary and/or secondary antibody.
Decrease the amount of purified protein or cell lysate loaded on the gel.
Possible reasons:
Ensure that reagents are stored properly. If possible, prepare fresh reagents prior to each experiment.
Verify that the blocking reagent (e.g., non-fat powdered milk) is completely dissolved. If necessary, filter the blocking reagent.
Possible reasons:
Verify that the SDS-PAGE gel mix is correctly prepared and that the poured gel polymerizes completely. For gels stored at 4°C, confirm that they have not dried out.
Slow the SDS-PAGE gel running speed by reducing the voltage.
“Smiling” of migrating proteins can be caused by excessive running temperatures. To prevent this, run the gel at a lower voltage or cool the gel by running it in a cold room or on ice.
Possible reasons:
Confirm that all air bubbles are removed before transfer.
Verify that the membrane is covered by a sufficient volume of reagents during incubation.
Possible reasons:
Confirm that all air bubbles are removed before transfer.
Verify that the membrane is covered by a sufficient volume of reagents during incubation.
Load positive and negative controls to ensure the ICC/IF procedure is performed correctly. ICC/IF results can vary depending on the protocol, so we recommend following the provided procedure first.
Possible reasons:
Consult the literature to confirm cell/tissue expression of the target protein and perform a western blot to detect the target protein in the target cell or tissue. As an alternative, use a transfected cell line.
Increase incubation time in permeabilization buffer. Use Triton X-100 or NP40 to permeabilize cell if the target protein is located in the nucleus.
Choose the best method for sample fixation. For example, 4% paraformaldehyde may be more appropriate for membrane-associated proteins. Organic solvents (e.g., methanol or ethanol) may not be suitable for membrane-associated proteins.
Adjust the concentration of primary antibody or secondary antibody. Confirm that the primary and secondary antibodies are compatible (i.e., if your primary antibody was raised in rabbit, use a secondary antibody that reacts with rabbit).
Adjust the incubation time with the primary antibody (e.g., incubate overnight at 4°C).
Store fluorophore-conjugated antibodies in the dark. Always protect the secondary antibody from light during the experiment.
Wash the slides gently and do not soak in washing buffer for extended periods of time.
Ensure that the appropriate blocking buffer is being used.
Reduce the salt concentration in the binding or washing buffers.
Possible reasons:
Please note that overexpression of the protein may lead to aberrant localization.
Reduce the concentration of the primary or secondary antibody.
Include a “secondary antibody only” control in which slides are incubated in the presence of secondary antibody alone (without primary antibody).
Incubate the sample with primary antibody at 4°C.
Decrease the time of incubation with primary or secondary antibody.
Reduce the time of fixation.
Select a suitable blocking reagent. Make sure that the IgG in blocking reagent (i.e., in normal serum or in some BSA preps) will not cross-react with the secondary antibody.
Increase the number and/or duration of washing steps.
Maintain the samples in humid conditions during the experiment.
Load positive and negative controls to ensure the IHC procedure is performed correctly. IHC results can vary depending on the protocol, so we recommend following the provided procedure first.
Possible reasons:
Consult the literature to confirm tissue expression of the target protein and perform a western blot to detect the target protein in the selected tissue sample.
Perform the recommended antigen retrieval method to unmask the epitope. It may be necessary to reduce the duration of fixation.
Adjust the concentration of primary antibody or secondary antibody. Make sure the primary and secondary antibodies are compatible (i.e., if your primary antibody was raised in rabbit, use a secondary antibody that reacts with rabbit).
Adjust the incubation time with the primary antibody (e.g., incubate overnight at 4°C).
Store fluorophore-conjugated antibodies in the dark. Always protect the secondary antibody from light during the experiment.
Adjust the time of deparaffinization. Make sure the xylene solution is fresh.
Wash the slides gently and do not soak in washing buffer for extended periods of time.
Ensure that the appropriate blocking buffer is being used.
Possible reasons:
Please note that overexpression of the protein may lead to aberrant localization.
Reduce the concentration of the primary or secondary antibody.
Include a “secondary antibody only” control in which slides are incubated in the presence of secondary antibody alone (without primary antibody).
Incubate the sample with primary antibody at 4°C.
Decrease the incubation time for the primary or secondary antibody.
Select a suitable blocking reagent. Make sure that the IgG in blocking reagent (i.e., in normal serum or in some BSA preps) will not cross-react with the secondary antibody.
Increase the number and/or duration of washing steps.
If using a peroxidase-conjugated secondary antibody, pretreat the sample with the Endogenous Peroxidase Blocking Kit (GTX30967) prior to incubation with primary antibody.
If using an alkaline phosphatase-conjugated secondary antibody, pretreat the sample with the Endogenous Alkaline Phosphatase Blocking Kit (GTX30968) prior to applying the AP system used for detection.
Pretreat the sample with the Avidin/Biotin Blocking Kit (GTX30966) or Streptavidin/Biotin Blocking Kit (GTX30965) prior to incubation with primary antibody.
Maintain the samples in humid conditions during the experiment